Annual Drug Patent Expirations for BETHKIS
Bethkis is a drug marketed by Chiesi and is included in one NDA. It is available from two suppliers. There are three patents protecting this drug and one Paragraph IV challenge.
Drug patent litigation for BETHKIS.
This drug has thirty-four patent family members in twenty-six countries.
The generic ingredient in BETHKIS is tobramycin. Two suppliers are listed for this compound. Additional details are available on the tobramycin profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
